Sponsor content
4 result(s) found, displaying 1 to 4
-
Australian public assessment report (AusPar)JOENJA (Leniolisib) is for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS) in adults and adolescents 12 years of age and older
-
Prescription medicine registrationActive ingredients: leniolisib phosphate.
-
-